Samarth Kulkarni, CEO: Crispr Therapeutics CRSP Sell · Filed 03/17

Trade details

Type: Insider sale
Amount: $499,442.74
Shares · price: 10,349 sh · $48.26 a share
Held after: 245,834 sh
Stock: Crispr Therapeutics CRSP
Person: Samarth KulkarniCEO
Trade date: 26/03/16
Filed: 26/03/17
Days to filing: 1 days

Sold 4.0% of holdings

Share of holding sold: 4.0%

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 02/14~04/15

Samarth Kulkarni's recent trades

Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$468.7K
10,020 sh
$468.7K
Filed 03/24
Traded 03/23
Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$517.3K
9,798 sh
$517.3K
Filed 03/12
Traded 03/11
Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$366.3K
6,967 sh
$366.3K
Filed 02/20
Traded 02/19
Samarth KulkarniCEO
Sell10b5-1 planCrispr Therapeutics
Sell10b5-1 plan
Crispr Therapeutics
CRSP
$3.6M
60,000 sh
$3.6M
Filed 01/22
Traded 01/22
Samarth KulkarniCEO
Sell10b5-1 planCrispr Therapeutics
Sell10b5-1 plan
Crispr Therapeutics
CRSP
$1.1M
21,433 sh
$1.1M
Filed 01/22
Traded 01/20